192 related articles for article (PubMed ID: 31648499)
1. [Predictive value of quantitative dynamic contrast-enhanced magnetic resonance imaging for the efficacy of neoadjuvant chemotherapy in locally advanced gastric cancer].
Zhu YJ; Li Y; Jiang J; Zhang W; Xue LY; Zhou AP; Jiang LM
Zhonghua Zhong Liu Za Zhi; 2019 Oct; 41(10):765-770. PubMed ID: 31648499
[No Abstract] [Full Text] [Related]
2. Quantitative Dynamic-Enhanced MRI and Intravoxel Incoherent Motion Diffusion-Weighted Imaging for Prediction of the Pathological Response to Neoadjuvant Chemotherapy and the Prognosis in Locally Advanced Gastric Cancer.
Zhu Y; Jiang Z; Wang B; Li Y; Jiang J; Zhong Y; Wang S; Jiang L
Front Oncol; 2022; 12():841460. PubMed ID: 35425711
[TBL] [Abstract][Full Text] [Related]
3. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) for pretreatment prediction of neoadjuvant chemotherapy response in locally advanced hypopharyngeal cancer.
Guo W; Zhang Y; Luo D; Yuan H
Br J Radiol; 2020 Nov; 93(1115):20200751. PubMed ID: 32915647
[No Abstract] [Full Text] [Related]
4. Dynamic contrast-enhanced and diffusion-weighted MR imaging in early prediction of pathologic response to neoadjuvant chemotherapy in locally advanced gastric cancer.
Li J; Yan LL; Zhang HK; Wang Y; Xu SN; Li HL; Qu JR
Abdom Radiol (NY); 2022 Oct; 47(10):3394-3405. PubMed ID: 35916943
[TBL] [Abstract][Full Text] [Related]
5. [Application on the quantitative perfusion parameters of dynamic contrast-enhanced MRI in the pathological subtype of uterine leiomyoma].
Zheng J; Zhao ZH; Yang JF; Zhao L; Yang LM; Hu HJ
Zhonghua Yi Xue Za Zhi; 2017 Apr; 97(15):1155-1159. PubMed ID: 28427122
[No Abstract] [Full Text] [Related]
6. Value of quantitative dynamic contrast-enhanced and diffusion-weighted magnetic resonance imaging in predicting extramural venous invasion in locally advanced gastric cancer and prognostic significance.
Zhu Y; Zhou Y; Zhang W; Xue L; Li Y; Jiang J; Zhong Y; Wang S; Jiang L
Quant Imaging Med Surg; 2021 Jan; 11(1):328-340. PubMed ID: 33392032
[TBL] [Abstract][Full Text] [Related]
7. Integrating dynamic contrast-enhanced magnetic resonance imaging and diffusion kurtosis imaging for neoadjuvant chemotherapy assessment of nasopharyngeal carcinoma.
Zheng D; Lai G; Chen Y; Yue Q; Liu X; Chen X; Chen W; Chan Q; Chen Y
J Magn Reson Imaging; 2018 Nov; 48(5):1208-1216. PubMed ID: 29693765
[TBL] [Abstract][Full Text] [Related]
8. Diffusion kurtosis imaging in the prediction of poor responses of locally advanced gastric cancer to neoadjuvant chemotherapy.
Fu J; Tang L; Li ZY; Li XT; Zhu HF; Sun YS; Ji JF
Eur J Radiol; 2020 Jul; 128():108974. PubMed ID: 32416553
[TBL] [Abstract][Full Text] [Related]
9. Prediction of the response of ocular adnexal lymphoma to chemotherapy using combined pretreatment dynamic contrast-enhanced and diffusion-weighted MRI.
Guo P; Liu Z; Yan F; Wang J; Wei L; Lv H; Wang Z; Xian J
Acta Radiol; 2016 Dec; 57(12):1490-1496. PubMed ID: 27012277
[TBL] [Abstract][Full Text] [Related]
10. [The value of DCE-MRI in predicting IDH gene mutation of high-grade gliomas].
Lu HT; Xing W; Zhang YW; Qin HP; Wu RH; Ding JL
Zhonghua Yi Xue Za Zhi; 2019 Oct; 99(39):3105-3109. PubMed ID: 31648456
[No Abstract] [Full Text] [Related]
11. Evaluation of the efficacy of neoadjuvant chemotherapy for breast cancer using diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging.
Xu HD; Zhang YQ
Neoplasma; 2017; 64(3):430-436. PubMed ID: 28253722
[TBL] [Abstract][Full Text] [Related]
12. Early changes in functional dynamic magnetic resonance imaging predict for pathologic response to neoadjuvant chemotherapy in primary breast cancer.
Ah-See ML; Makris A; Taylor NJ; Harrison M; Richman PI; Burcombe RJ; Stirling JJ; d'Arcy JA; Collins DJ; Pittam MR; Ravichandran D; Padhani AR
Clin Cancer Res; 2008 Oct; 14(20):6580-9. PubMed ID: 18927299
[TBL] [Abstract][Full Text] [Related]
13. Role of dynamic contrast-enhanced MRI in predicting severe acute radiation-induced rectal injury in patients with rectal cancer.
Chen Y; Ding L; Zhang ZW; Wu XH; Que YT; Ma YR; Liu YY; Wen ZQ; Yang XY; Lu BL; Bao Y; Niu SQ; Yu SP
Eur Radiol; 2024 Mar; 34(3):1471-1480. PubMed ID: 37665390
[TBL] [Abstract][Full Text] [Related]
14. The predictive value of quantitative DCE metrics for immediate therapeutic response of high-intensity focused ultrasound ablation (HIFU) of symptomatic uterine fibroids.
Wei C; Fang X; Wang CB; Chen Y; Xu X; Dong JN
Abdom Radiol (NY); 2018 Aug; 43(8):2169-2175. PubMed ID: 29204677
[TBL] [Abstract][Full Text] [Related]
15. The value of GRASP on DCE-MRI for assessing response to neoadjuvant chemotherapy in patients with esophageal cancer.
Lu Y; Ma L; Qin J; Wang Z; Guo J; Zhao Y; Zhang H; Yan X; Liu H; Li H; Kamel IR; Qu J
BMC Cancer; 2019 Oct; 19(1):999. PubMed ID: 31651280
[TBL] [Abstract][Full Text] [Related]
16. Multiparametric MRI-based radiomics nomogram for early prediction of pathological response to neoadjuvant chemotherapy in locally advanced gastric cancer.
Li J; Yin H; Wang Y; Zhang H; Ma F; Li H; Qu J
Eur Radiol; 2023 Apr; 33(4):2746-2756. PubMed ID: 36512039
[TBL] [Abstract][Full Text] [Related]
17. Early Prediction of Response to Neoadjuvant Chemotherapy Using Dynamic Contrast-Enhanced MRI and Ultrasound in Breast Cancer.
Kim Y; Kim SH; Song BJ; Kang BJ; Yim KI; Lee A; Nam Y
Korean J Radiol; 2018; 19(4):682-691. PubMed ID: 29962874
[TBL] [Abstract][Full Text] [Related]
18. Combined dynamic DCE-MRI and diffusion-weighted imaging to evaluate the effect of neoadjuvant chemotherapy in cervical cancer.
Feng Y; Liu H; Ding Y; Zhang Y; Liao C; Jin Y; Ai C
Tumori; 2020 Apr; 106(2):155-164. PubMed ID: 31736439
[TBL] [Abstract][Full Text] [Related]
19. [Diagnostic value of quantitative pharmacokinetic parameters and relative quantitative pharmacokinetic parameters in breast lesions with dynamic contrast-enhanced MRI].
Sun TT; Liu WH; Zhang YQ; Li LH; Wang R; Ye YY
Zhonghua Yi Xue Za Zhi; 2017 Aug; 97(29):2266-2270. PubMed ID: 28780840
[No Abstract] [Full Text] [Related]
20. Multiparametric magnetic resonance imaging for predicting pathological response after the first cycle of neoadjuvant chemotherapy in breast cancer.
Li X; Abramson RG; Arlinghaus LR; Kang H; Chakravarthy AB; Abramson VG; Farley J; Mayer IA; Kelley MC; Meszoely IM; Means-Powell J; Grau AM; Sanders M; Yankeelov TE
Invest Radiol; 2015 Apr; 50(4):195-204. PubMed ID: 25360603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]